=?UTF-8?B?QXV0b2ltbXVuZSBoZW1vbHl0aWMgYW5lbWlhIGluIHJlbGFwc2VkIGFuZ2lvaW1tdW5vYmxhc3RpYyBULWNlbGwgbHltcGhvbWE6IGEgY2FzZSByZXBvcnQ=?=

Autoimmune hemolytic anemia (AIHA) is a rare hematologic disorder that may occur as a primary disease or develop secondary to autoimmune diseases, infections, or malignant lymphoma. In patients with malignant lymphoma, AIHA is clinically important because it has been associated with unfavorable treatment outcomes. A 75-year-old woman with a prior diagnosis of angioimmunoblastic T-cell lymphoma (AITL) presented with recurrent fever, dyspnea, and jaundice after completing six cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemotherapy. Laboratory evaluation showed severe anemia, indirect hyperbilirubinemia, low haptoglobin, and positive direct and indirect antiglobulin (Coombs) tests, supporting a diagnosis of AIHA; a low-titer cold agglutinin was also detected. 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) demonstrated findings consistent with relapsed AITL. Although she had no meaningful early response to corticosteroid monotherapy, hemolytic parameters improved and PET/CT showed a partial metabolic response after ICE (ifosfamide, carboplatin, and etoposide) chemotherapy. After six cycles of ICE chemotherapy, her blood counts and hemolytic markers had normalized, PET/CT continued to show a partial metabolic response, and her performance status had improved substantially. This case shows that AIHA can occur concurrently with AITL relapse. Clinicians should consider AIHA when patients with lymphoma present with clinical or laboratory findings suggestive of hemolysis. In this setting, assessment of lymphoma disease activity and treatment of the underlying lymphoma may be important components of management. Further studies of the immunopathogenesis of AIHA in malignant lymphoma are needed to improve diagnosis and treatment.

Authors

Institutions

Publication Details

Journal
Kosin Medical Journal
Published
2026-11-17
DOI
https://doi.org/10.7180/kmj.26.175
Primary Topic
Blood groups and transfusion
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

=?UTF-8?B?QXV0b2ltbXVuZSBoZW1vbHl0aWMgYW5lbWlhIGluIHJlbGFwc2VkIGFuZ2lvaW1tdW5vYmxhc3RpYyBULWNlbGwgbHltcGhvbWE6IGEgY2FzZSByZXBvcnQ=?=

Dong Won Baek, Youngeun Jang
4 links
Kosin Medical Journal
Blood groups and transfusion
article

=?UTF-8?B?QXV0b2ltbXVuZSBoZW1vbHl0aWMgYW5lbWlhIGluIHJlbGFwc2VkIGFuZ2lvaW1tdW5vYmxhc3RpYyBULWNlbGwgbHltcGhvbWE6IGEgY2FzZSByZXBvcnQ=?=

Dong Won Baek, Youngeun Jang
article en

Abstract

Autoimmune hemolytic anemia (AIHA) is a rare hematologic disorder that may occur as a primary disease or develop secondary to autoimmune diseases, infections, or malignant lymphoma. In patients with malignant lymphoma, AIHA is clinically important because it has been associated with unfavorable treatment outcomes. A 75-year-old woman with a prior diagnosis of angioimmunoblastic T-cell lymphoma (AITL) presented with recurrent fever, dyspnea, and jaundice after completing six cycles of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisolone) chemotherapy. Laboratory evaluation showed severe anemia, indirect hyperbilirubinemia, low haptoglobin, and positive direct and indirect antiglobulin (Coombs) tests, supporting a diagnosis of AIHA; a low-titer cold agglutinin was also detected. 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) demonstrated findings consistent with relapsed AITL. Although she had no meaningful early response to corticosteroid monotherapy, hemolytic parameters improved and PET/CT showed a partial metabolic response after ICE (ifosfamide, carboplatin, and etoposide) chemotherapy. After six cycles of ICE chemotherapy, her blood counts and hemolytic markers had normalized, PET/CT continued to show a partial metabolic response, and her performance status had improved substantially. This case shows that AIHA can occur concurrently with AITL relapse. Clinicians should consider AIHA when patients with lymphoma present with clinical or laboratory findings suggestive of hemolysis. In this setting, assessment of lymphoma disease activity and treatment of the underlying lymphoma may be important components of management. Further studies of the immunopathogenesis of AIHA in malignant lymphoma are needed to improve diagnosis and treatment.

Kosin Medical Journal
Kyungpook National University Hospital (KR), Kyungpook National University (KR), Kyungpook National University Medical Center (KR)
Good health and well-being
Blood groups and transfusion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon